Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India

BACKGROUND: The aim of the study was to determine the efficacy of Fibroscan versus noninvasive markers, i.e. nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS); Aspartate-aminotransferase (AST)/platelet ratio (APRI); and AST/Alanine-aminotransferase (AAR) as a screening tool in NAFLD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathik, Parikh, Ravindra, Surude, Ajay, Choksey, Prasad, Bhate, Jatin, Patel, Prabha, Sawant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367221/
https://www.ncbi.nlm.nih.gov/pubmed/25830783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367221/
https://www.ncbi.nlm.nih.gov/pubmed/25830783

Ejemplares similares